The UAW's breakthrough in Tennessee could spark a wave of unionisation across the traditionally non-union South, creating unprecedented demand for automation solutions.
As wage costs rise, manufacturers will race to implement cutting-edge robotics and AI systems to maintain their competitive edge and protect profit margins.
This labour shift could trigger billions in factory modernisation investments, directly benefiting the automation and industrial technology companies in this group.
This basket's total market capitalisation is $235.57B. Its top-heavy composition is anchored by several large‑cap holdings, giving it a relatively stable profile.
ROK: $44.42B
SYM: $33.16B
PATH: $5.99B
The UAW's historic victory at Volkswagen's Chattanooga plant could spark a wave of unionisation across the American South. As labour costs rise, manufacturers will likely accelerate their adoption of automation and robotics to maintain competitiveness and operational efficiency.
This group focuses on companies that provide automation solutions, robotics, and productivity-enhancing technologies. These businesses are positioned to benefit from increased capital spending as manufacturers look to offset rising labour expenses through technological upgrades.
Each company was carefully selected for their role in industrial automation and digital transformation. From AI-powered robotics to machine vision systems, these firms offer the technologies that manufacturers need to modernise their operations and stay competitive.
Volkswagen's Chattanooga plant workers have ratified their first UAW contract, a major victory for organized labor in the U.S. South. This could catalyze further unionization efforts across the region, creating opportunities for companies that help manufacturers enhance productivity and automate processes to mitigate rising labor expenses.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Published on February 20
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+2
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitiv Ltd.
If you invested across these assets:
In 12 months it might be worth:
+20.12%
On average, analysts expect assets in this group to grow 20.12% over the next year.
8 of 12 assets in this group are rated Buy by professional analysts.
